1. Inicio
  2. Publicaciones
  3. Correction: Management and outcome of children with high-risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease.

Correction: Management and outcome of children with high-risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Rubio-Aparicio, Pedro M
  • Rubio-San-Simon, Alba
  • Moreno, Lucas
  • Mazorra, Paula
  • Almaraz, Ricardo Lopez
  • Lopez, Mercedes Llempen
  • Bermudez, Mar
  • Jimenez, Irene
  • Ramal, Desiree

Grupos

Abstract

In this article the statement in the Funding information section was incorrectly given as ‘Publication funded by the European Union-Next GenerationEU’ and should have read ‘This study has been co-funded by Instituto de Salud Carlos III (ISCIII) through the project “ICI21/00098” with funds from Plan de Recuperación, Transformación y Resiliencia and “Funded by the European Union – NextGenerationEU”’. The original article has been corrected. © The Author(s) 2025.

Datos de la publicación

ISSN/ISSNe:
1699-048X, 1699-3055

Clinical & Translational Oncology  SPRINGER INT PUBL AG

Tipo:
Correction
Páginas:
3558-3558
PubMed:
40202583
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,764 SCImago ℠
Cuartil:
Q2 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Keywords

  • child; erratum; human; controlled study; diagnosis; drug therapy; oral drug administration; special situation for pharmacovigilance; surgery

Cita

Compartir